The Impact of Drug Interactions with Tyrosine Kinase Inhibitors on Adverse Event Development based on the changes of drug concentration level: Meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Impact of Drug Interactions with Tyrosine Kinase Inhibitors on Adverse Event Development based on the changes of drug concentration level: Meta-analysis

Published:2024-03-31 Issue:1 Volume:34 Page:71-78
ISSN:1226-6051
Container-title:Korean Journal of Clinical Pharmacy
language:en
Short-container-title:Korean J Clin Pharm

Author:

Hwang JinAh¹,Lee Heeyoung²

Affiliation:

1. Department of Medicinal Biosciences, Konyang University, Nonsan, 32992, Republic of Korea

2. Department of Pharmacy, Inje University, Gimhae, 50834, Republic of Korea

Publisher

The Korean College of Clinical Pharmacy

Link

https://pdf.medrang.co.kr/KJCP/2024/034/KJCP034-01-06.pdf

Reference24 articles.

1. The high price of anticancer drugs: origins, implications, barriers, solutions

2. Oral Anticancer Therapy: Management of Drug Interactions

3. Dermatological adverse drug reactions to tyrosine kinase inhibitors: a narrative review

4. Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020)

5. Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP